BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1162 related articles for article (PubMed ID: 17694074)

  • 21. Histone deacetylase inhibitors.
    Marks PA; Richon VM; Miller T; Kelly WK
    Adv Cancer Res; 2004; 91():137-68. PubMed ID: 15327890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The viral control of cellular acetylation signaling.
    Caron C; Col E; Khochbin S
    Bioessays; 2003 Jan; 25(1):58-65. PubMed ID: 12508283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A decade of histone acetylation: marking eukaryotic chromosomes with specific codes.
    Kimura A; Matsubara K; Horikoshi M
    J Biochem; 2005 Dec; 138(6):647-62. PubMed ID: 16428293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deacetylation of nonhistone proteins by HDACs and the implications in cancer.
    Peng L; Seto E
    Handb Exp Pharmacol; 2011; 206():39-56. PubMed ID: 21879445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone modifying enzymes and cancer: going beyond histones.
    Zhang K; Dent SY
    J Cell Biochem; 2005 Dec; 96(6):1137-48. PubMed ID: 16173079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone deacetylases: complex transducers of nuclear signals.
    Johnson CA; Turner BM
    Semin Cell Dev Biol; 1999 Apr; 10(2):179-88. PubMed ID: 10441071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
    Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
    Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone deacetylases as transducers and targets of nuclear signaling.
    Walkinshaw DR; Tahmasebi S; Bertos NR; Yang XJ
    J Cell Biochem; 2008 Aug; 104(5):1541-52. PubMed ID: 18425769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional regulation by the acetylation of nonhistone proteins in humans -- a new target for therapeutics.
    Das C; Kundu TK
    IUBMB Life; 2005 Mar; 57(3):137-49. PubMed ID: 16036576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone post-translational modification: from discovery to the clinic.
    Thomas NR
    IDrugs; 2006 Jun; 9(6):398-401. PubMed ID: 16752306
    [No Abstract]   [Full Text] [Related]  

  • 31. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
    Lin T; Chen H; Koustova E; Sailhamer EA; Li Y; Shults C; Liu B; Rhee P; Kirkpatrick J; Alam HB
    Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of histone and transcription factor acetylation in diabetes pathogenesis.
    Gray SG; De Meyts P
    Diabetes Metab Res Rev; 2005; 21(5):416-33. PubMed ID: 15906405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation.
    Pollack BP; Sapkota B; Boss JM
    Photochem Photobiol; 2009; 85(3):652-62. PubMed ID: 19076306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in the discovery of small molecule histone deacetylase inhibitors.
    Remiszewski SW
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):487-99. PubMed ID: 12197307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.
    Vaquero A; Sternglanz R; Reinberg D
    Oncogene; 2007 Aug; 26(37):5505-20. PubMed ID: 17694090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of histone acetylation in cell physiology and diseases: An update.
    Khan SN; Khan AU
    Clin Chim Acta; 2010 Oct; 411(19-20):1401-11. PubMed ID: 20598676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.
    Boyault C; Sadoul K; Pabion M; Khochbin S
    Oncogene; 2007 Aug; 26(37):5468-76. PubMed ID: 17694087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetics and the estrogen receptor.
    Leader JE; Wang C; Popov VM; Fu M; Pestell RG
    Ann N Y Acad Sci; 2006 Nov; 1089():73-87. PubMed ID: 17261756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible acetylation of non histone proteins: role in cellular function and disease.
    Batta K; Das C; Gadad S; Shandilya J; Kundu TK
    Subcell Biochem; 2007; 41():193-212. PubMed ID: 17484129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics.
    Selvi RB; Kundu TK
    Biotechnol J; 2009 Mar; 4(3):375-90. PubMed ID: 19296442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.